The progression of Parkinson's disease often requires a change of therapy. An expert explains when this should be done and ...

People with Parkinson’s disease are to benefit from cutting edge AI technology that allows neuroscientists to safely test medication and treatment on a ‘digital twin’ brain, thanks to a £1m funding ...

This report offers insights into recent health news, encompassing advancements in Parkinson's and cancer treatments, ...

Tavapadon met the primary endpoint in the pivotal Phase 3 TEMPO-2 flexible-dose monotherapy trial, demonstrating a statistically significant improvement from baseline in the MDS-UPDRS Parts II and III ...

Critically, they find that immune challenge is ... A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating ...

Participants completed self-report questionnaires (Geriatric Depression Scale, Parkinson's Anxiety Scale, Parkinson's Disease Questionnaire-39 ... understanding of EMST and TS to determine if they are ...

We think UCB is in good financial health, with solid earnings and cash flow generation. UCB has deleveraged over the years, and it ended 2023 with about EUR 2.2 billion in net debt on its balance ...

I’ve described Parkinson’s as an “unforgiving” disease and a “slow crawl into the brambles.” Kathy is the love of my life.

Therefore, it's important that health professionals conduct a detailed patient history, including history of exposure to ticks when assessing individuals with signs or symptoms suggestive of Lyme ...

Credit: Stock-Asso/Shutterstock. Arrowhead Pharmaceuticals has entered a worldwide licensing and partnership agreement with Sarepta Therapeutics to develop treatments for rare genetic diseases.

However, viral STIs are managed rather than cured—either to prevent a recurrence, slow disease progression, or monitor for complications. Viral STIs like HSV, chronic hepatitis B, and HIV are ...